Nektar Therapeutics NKTR
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$9.39M-20.4% YoY
Operating profit-$59.31M-88.1% YoY
Net profit-$55.65M-56.7% YoY
Diluted EPS-$1.63+12.8% YoY
Free cash flow-$72.33M-48.0% YoY
Operating cash flow-$71.93M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Operating margin-303.6%
Net margin-339.7%
Return on equity-37.9%
Return on assets-26.5%
Return on invested capital-31.6%
Current ratio9.00
Liabilities / assets18.1%
Cash & investments$614.36M
Total debt$51.00M
Net cash (debt)$563.36M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $9.39M | $10.13M | $10.86M | $55.23M | $21.81M |
| Total Operating Revenue | $9.39M | $10.13M | $10.86M | $55.23M | $21.81M |
| Operating Expense | $68.69M | $51.89M | $49.12M | $186.00M | $40.90M |
| Selling and Admin Expenses | $24.57M | $12.77M | $13.44M | $68.67M | $11.19M |
| -General & Admin Expense | $24.57M | $12.77M | $13.44M | $68.67M | $11.19M |
| Research & Development | $44.12M | $39.13M | $35.68M | $117.33M | $29.71M |
| Operating Profit | -$59.31M | -$41.76M | -$38.26M | -$130.77M | -$19.09M |
| Net Non-Operating Interest Income (Expense) | $2.82M | $2.14M | -$3.70M | -$15.75M | -$6.99M |
| Non-Operating Interest Income | $9.58M | $9.35M | $4.24M | $10.44M | $2.78M |
| Non-Operating Interest Expense | $6.76M | $7.21M | $7.94M | $26.18M | $9.77M |
| Other Income (Expense) | $1.45M | -$678,000.00 | -$1.13M | -$8.97M | -$8.62M |
| Special Income (Charges) | $1.50M | -$578,000.00 | -$796,000.00 | -$9.33M | -$8.58M |
| -Less:Restructuring and Mergern & Acquisition | -$1.50M | $578,000.00 | $796,000.00 | $4.89M | $4.13M |
| Other Non-Operating Income (Expenses) | -$59,000.00 | -$100,000.00 | -$336,000.00 | $361,000.00 | -$44,000.00 |
| Pretax Profit | -$55.05M | -$40.30M | -$43.09M | -$155.49M | -$34.70M |
| Tax | $22,000.00 | $2,000.00 | $64,000.00 | -$138,000.00 | $31,000.00 |
| $583,000.00 | $319,000.00 | $1.75M | $8.73M | $1.35M | |
| Net Profit | -$55.65M | -$40.62M | -$44.90M | -$164.08M | -$36.08M |
| Profit from Continuing Operations | -$55.65M | -$40.62M | -$44.90M | -$164.08M | -$36.08M |
| Net Income to Parent Company | -$55.65M | -$40.62M | -$44.90M | -$164.08M | -$36.08M |
| Net Income to Common Stockholders | -$55.65M | -$40.62M | -$44.90M | -$164.08M | -$36.08M |
| Basic EPS | -$1.63 | -$1.23 | -$1.82 | -$9.73 | -$1.78 |
| Diluted EPS | -$1.63 | -$1.23 | -$1.82 | -$9.73 | -$1.78 |
| Cost of Revenue | – | – | – | $0.00 | $0.00 |
| Gross Profit | – | – | – | $55.23M | $21.81M |
| -Less:Impairment of Capital Assets | – | – | – | $4.44M | $4.44M |
| -Gain on Sale Of Business | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.04B | $1.10B | $763.27M | $280.41M | $280.41M |
| Total Current Assets | $679.33M | $739.40M | $589.04M | $266.27M | $266.27M |
| Cash and Cash Equivalents & Short-Term Investments | $614.36M | $684.34M | $568.60M | $245.75M | $245.75M |
| -Cash and Cash Equivalents | $34.69M | $39.27M | $149.58M | $15.12M | $15.12M |
| -Short Term Investments | $579.67M | $645.07M | $419.03M | $230.64M | $230.64M |
| Receivables | $9.01M | $4.76M | $3.60M | $1.78M | $1.78M |
| -Accrued Interest Receivable | $6.13M | – | – | – | – |
| -Other Receivables | $2.88M | $4.76M | $3.60M | $1.78M | $1.78M |
| Prepaid Assets | $55.97M | $50.31M | $16.84M | $18.74M | $18.74M |
| Total Non-Current Assets | $357.92M | $355.73M | $174.23M | $14.14M | $14.14M |
| Net PPE | $4.34M | $4.26M | – | $5.00M | $5.00M |
| -Gross PPE | $4.34M | $4.26M | – | $5.00M | $5.00M |
| Investments and Advances | $339.34M | $340.48M | $162.99M | $3.49M | $3.49M |
| -Long Term Equity Investment | $839,000.00 | $1.42M | – | $3.49M | $3.49M |
| Non-Current Prepaid Assets | $11.69M | $8.67M | – | – | – |
| Other Non-Current Assets | $2.55M | $2.32M | $11.24M | $5.65M | $5.65M |
| Total Liabilities | $187.53M | $192.01M | $187.06M | $190.57M | $190.57M |
| Total Current Liabilities | $75.48M | $70.99M | $57.71M | $53.54M | $53.54M |
| Payables | $18.13M | $24.89M | $10.03M | $10.77M | $10.77M |
| -Accounts Payable | $18.13M | $24.89M | $10.03M | $10.77M | $10.77M |
| Current Accrued Expenses | $24.43M | $16.36M | $20.14M | $19.33M | $19.33M |
| Short-Term Debt and Capital Lease Obligation | $22.88M | $22.71M | $22.53M | $20.50M | $20.50M |
| -Current Capital Lease Obligation | $22.88M | $22.71M | $22.53M | $20.50M | $20.50M |
| Total Non-Current Liabilities | $112.05M | $121.02M | $129.35M | $137.04M | $137.04M |
| Long Term Debt and Capital Lease Obligation | $51.00M | $55.85M | $60.63M | $65.26M | $65.26M |
| -Long Term Capital Lease Obligation | $51.00M | $55.85M | $60.63M | $65.26M | $65.26M |
| Other Non-Current Liabilities | $61.05M | $65.17M | $68.72M | $71.78M | $71.78M |
| Total Equity | $849.72M | $903.12M | $576.22M | $89.83M | $89.83M |
| Stockholders' Equity | $849.72M | $903.12M | $576.22M | $89.83M | $89.83M |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $2,000.00 | $2,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $2,000.00 | $2,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $4.76B | $4.75B | $4.38B | $3.85B | $3.85B |
| Retained Earnings | -$3.90B | -$3.85B | -$3.81B | -$3.76B | -$3.76B |
| Less: Treasury Stock | $0.00 | $0.00 | – | $0.00 | $0.00 |
| Gains/Losses Not Affecting Retained Earnings | -$3.95M | -$1.76M | -$1.03M | $17,000.00 | $17,000.00 |
| -Available for Sale Securities | – | – | $162.99M | – | – |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$71.93M | -$75.77M | -$44.30M | -$208.51M | -$64.96M |
| Net cash flow from continuing operations | -$71.93M | -$75.77M | -$44.30M | -$208.51M | -$64.96M |
| Net Income from Continuing Operations | -$55.65M | -$40.62M | -$44.90M | -$164.08M | -$36.08M |
| Gain/Loss from Continuing Operations | $583,000.00 | $319,000.00 | $1.75M | $8.73M | $1.35M |
| Depreciation & Depletion & Amortization | $169,000.00 | $156,000.00 | $151,000.00 | $1.03M | $190,000.00 |
| Other Non-Cash Items | -$2.62M | -$1.26M | -$4.58M | -$28.75M | -$12.04M |
| Change in Working Capital | -$14.63M | -$32.49M | -$68,000.00 | -$37.02M | -$23.12M |
| -Change in Payables and Accrued Expense | $3.04M | $12.77M | $1.39M | -$6.41M | -$7.52M |
| -Change in Other Current Assets | -$13.17M | -$40.83M | $949,000.00 | -$15.45M | -$9.86M |
| -Change In Other Working Capital | -$4.50M | -$4.43M | -$2.41M | -$15.16M | -$5.75M |
| Net cash flow from investing | $66.90M | -$399.11M | -$350.79M | -$1.20M | $372,000.00 |
| Net Cash Flow from Continuing Investing Activities | $66.90M | -$399.11M | -$350.79M | -$1.20M | $372,000.00 |
| Net PPE Purchase and Sale | -$398,000.00 | -$94,000.00 | -$18,000.00 | -$171,000.00 | -$18,000.00 |
| Net Investment Purchase and Sale | $67.30M | -$399.02M | -$350.77M | -$329,000.00 | $390,000.00 |
| Financing Cash Flow | $448,000.00 | $364.57M | $529.55M | $180.57M | $38.67M |
| Net Cash Flow from Continuing Financing Activities | $448,000.00 | $364.57M | $529.55M | $180.57M | $38.67M |
| Net Common Stock Issuance | $0.00 | $364.91M | $525.52M | $180.85M | $38.26M |
| Proceeds from Stock Option Exercised | $698,000.00 | $878,000.00 | $4.06M | $866,000.00 | $410,000.00 |
| Net Other Financing Charges | -$250,000.00 | -$1.21M | -$25,000.00 | -$1.15M | $0.00 |
| Ending Cash Balance | $34.69M | $39.27M | $149.58M | $15.12M | $15.12M |
| Net Change in Cash | -$4.58M | -$110.31M | $134.46M | -$29.14M | -$25.92M |
| Beginning Cash Balance | $39.27M | $149.58M | $15.12M | $44.25M | $41.03M |
| Effect of Exchange Rate Changes | $0.00 | $0.00 | $0.00 | $6,000.00 | $0.00 |
| Free Cash Flow | -$72.33M | -$75.86M | -$44.32M | -$208.68M | -$64.98M |
| -Change in Receivables | – | – | – | $0.00 | $0.00 |
| -Change in Inventory | – | – | – | $0.00 | $0.00 |
| Net Business Purchase and Sale | – | – | – | -$697,000.00 | – |
No comments yet — be the first to weigh in on NKTR.
Sign in to join the discussion.